FdaApplication
ANDA 203277
Identifiers
- fda_app_no: ANDA203277
Properties
| Property | Value |
|---|---|
| applicant_name | HETERO LABS LTD UNIT V |
| application_type | ANDA |
| approval_date | 2014-01-06 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LAMIVUDINE | LAMIVUDINE | 150MG | TABLET;ORAL |
| LAMIVUDINE | LAMIVUDINE | 300MG | TABLET;ORAL |
2 products